Italia Markets close in 4 hrs 21 mins
  • CTI BioPharma Announces Publication of Article Highlighting Pacritinib Data from the PAC203 Phase 2 Study in Myelofibrosis in Blood Advances
    PR Newswire

    CTI BioPharma Announces Publication of Article Highlighting Pacritinib Data from the PAC203 Phase 2 Study in Myelofibrosis in Blood Advances

    CTI BioPharma Corp. (Nasdaq: CTIC) today announced that an article highlighting pacritinib data was published in Blood Advances. The article, titled "Determining the Recommended Dose of Pacritinib: Results from the PAC203 Phase 2 Dose-Finding Study in Patients with Advanced Myelofibrosis" is available online via this link.

  • Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications
    PR Newswire

    Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications

    Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Julie Dewey has joined the company as vice president, investor relations and corporate communications, effective immediately.

  • Nabors Announces Expiration and Final Results of Exchange Offers
    PR Newswire

    Nabors Announces Expiration and Final Results of Exchange Offers

    Nabors Industries, Inc. ("Nabors" or the "Company"), a wholly-owned subsidiary of Nabors Industries Ltd. ("Parent") (NYSE: NBR), today announced the final results of its offers to all Eligible Holders (as defined below) to exchange (the "Exchange Offers") (x) certain aggregate principal amounts of the Company's (i) 4.625% Senior Notes due 2021, (ii) 5.50% Senior Notes due 2023, (iii) 5.10% Senior Notes due 2023, (iv) 5.75% Senior Notes due 2025, and (v) 0.75% Senior Exchangeable Notes due 2024 and (y) certain aggregate principal amounts of Parent's (i) 7.25% Senior Guaranteed Notes due 2026 and (ii) 7.50% Senior Guaranteed Notes due 2028 (together, the "Old Notes") for up to $300 million aggregate principal amount of newly issued 9.00% senior priority guaranteed notes due 2025 (the "New Notes").